LAVA Medtech Acquisition Valuation
| LVACDelisted Stock | USD 10.44 0.00 0.00% |
At this time, the entity appears to be overvalued. LAVA Medtech Acquisition secures a last-minute Real Value of $8.85 per share. The latest price of the entity is $10.44. Our model forecasts the value of LAVA Medtech Acquisition from inspecting the entity fundamentals such as number of shares shorted of 6.82 K, and Shares Outstanding of 11.5 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that LAVA Medtech's price fluctuation is very steady at this time. Calculation of the real value of LAVA Medtech Acquisition is based on 3 months time horizon. Increasing LAVA Medtech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since LAVA Medtech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LAVA Stock. However, LAVA Medtech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.44 | Real 8.85 | Hype 10.44 | Naive 10.46 |
The real value of LAVA Stock, also known as its intrinsic value, is the underlying worth of LAVA Medtech Acquisition Company, which is reflected in its stock price. It is based on LAVA Medtech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of LAVA Medtech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of LAVA Medtech Acquisition helps investors to forecast how LAVA stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LAVA Medtech more accurately as focusing exclusively on LAVA Medtech's fundamentals will not take into account other important factors: LAVA Medtech Total Value Analysis
LAVA Medtech Acquisition is now forecasted to have valuation of 144.92 M with market capitalization of 149.93 M, debt of 92.81 K, and cash on hands of 1.15 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the LAVA Medtech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
144.92 M | 149.93 M | 92.81 K | 1.15 M |
LAVA Medtech Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of LAVA indicates not a very effective usage of assets in November.LAVA Medtech Ownership Allocation
The market capitalization of LAVA Medtech Acquisition is $149.93 Million. The majority of LAVA Medtech outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LAVA Medtech Acquisition to benefit from reduced commissions. Therefore, institutional holders are subject to a different set of regulations than regular investors in LAVA Medtech Acquisition. Please pay attention to any change in the institutional holdings of LAVA Medtech as this could imply that something significant has changed or is about to change at the company. Note, that even with substantial debt, if the true value of the entity is larger than the current market value, you may still be able to generate positive returns on investment in this company at some future point.LAVA Medtech Profitability Analysis
Net Income was 4.5 M with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates LAVA Medtech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in LAVA Medtech and how it compares across the competition.
About LAVA Medtech Valuation
The delisted stock valuation mechanism determines LAVA Medtech's current worth on a weekly basis. Our valuation model uses a comparative analysis of LAVA Medtech. We calculate exposure to LAVA Medtech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LAVA Medtech's related companies.LAVA Medtech Acquisition Corp. does not have significant operations. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP. Lava Medtech is traded on NASDAQ Exchange in the United States.
LAVA Medtech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 14.4 M | |
| Quarterly Earnings Growth Y O Y | -0.951 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in LAVA Stock
If you are still planning to invest in LAVA Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LAVA Medtech's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |